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ABSTRACT
The present study describes a genome-wide method
for biallelic mutagenesis in mammalian cells. Novel
poly(A) gene trap vectors, which contain features
for direct cloning vector–cell fusion transcripts and
for post-entrapment genome engineering, were
used to generate a library of 979 mutant ES cells.
The entrapment mutations generally disrupted gene
expression and were readily transmitted through
the germline, establishing the library as a resource
for constructing mutant mice. Cells homozygous
for most entrapment loci could be isolated by
selecting for enhanced expression of an inserted
neomycin-resistance gene that resulted from losses
of heterozygosity (LOH). The frequencies of LOH
measured at 37 sites in the genome ranged from
1.3 3 10
 5 to 1.2 3 10
 4 per cell and increased with
increasing distance from the centromere, implicat-
ing mitotic recombination in the process. The ease
and efficiency of obtaining homozygous mutations
will (i) facilitate genetic studies of gene function
in cultured cells, (ii) permit genome-wide studies
of recombination events that result in LOH and
mediate a type of chromosomal instability important
in carcinogenesis, and (iii) provide new strategies
for phenotype-driven mutagenesis screens in
mammalian cells.
INTRODUCTION
The number and diversity of genes identiﬁed by the mam-
malian genome projects suggests that considerable biology
remains to be characterized on a molecular level and has pro-
vided the impetus for developing genome-wide strategies to
characterize gene functions important in normal and disease
processes. Tagged sequence mutagenesis uses gene trap vec-
tors to disrupt genes in cultured cells combined with rapid,
DNA sequence-based screens to characterize the disrupted
genes at the nucleotide level. The approach has been widely
used to disrupt genes in mouse embryonic stem (ES) cells
(1–3). Gene trapping has also been used, but to a far lesser
extent, to identify genes responsible for recessive phenotypes
in somatic cells (4–9).
Mutagenesis of mammalian cells is hindered by the fact
that the autosomal genome is diploid and consequently, most
entrapment mutations are recessive. The problem is circum-
vented by gene-based studies in ES cells where selected
mutations can be transmitted through the mouse germline
and subsequently bred to a homozygous state. However,
gene inactivation in somatic cells requires pre-existing hem-
izygosity or spontaneous loss of heterozygosity; thus, even
with strategies to enhance the recovery of loss-of-function
mutations (4,5,7,10,11), gene trap mutagenesis has seen
only limited use in phenotype-driven screens.
Mammalian cells heterozygous at a given locus undergo
spontaneous conversion to a homozygous state by loss of het-
erozygosity (LOH) at frequencies of  10
 5 per cell (12–15).
Homozygous mutant cells can be selected based on pheno-
types caused by gene dosage effects. For example, mutations
involving the insertion of a neomycin-resistance gene (Neo)
may be converted to a homozygous state simply by selecting
for clones that survive in higher concentrations of G418 (16).
Levels of neomycin resistance correlate with levels of Neo
gene expression (17). Mitotic recombination, which appears
to be the preferred mechanism for spontaneous LOH
(13,14,18,19), generates cells homozygous for the inserted
Neo genes, and the increase in Neo gene copy number allows
moderately resistant cells to acquire higher levels of antibi-
otic resistance. However, unlike targeted mutations, LOH has
not been reliably achieved with mutations induced by gene
trapping. A major problem stems from variations in Neo
gene expression that can result, e.g. when the entrapment cas-
sette is expressed from different cellular promoters. In addi-
tion, some gene trap vectors use a ‘corrected’ version of the
Neo gene that induces higher levels of antibiotic resistance
than a widely used ‘mutant’ gene (20,21). Cells expressing
the corrected Neo gene may be insufﬁciently G418-sensitive
to select for LOH events (22). We reasoned that gene trap
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doi:10.1093/nar/gkl728mutations generated by a poly(A) trap (23–25) and that incor-
porate the less active Neo gene might be reproducibly con-
verted to homozygosity, if the resulting mutant clones
expressed similar, moderate levels of neomycin resistance.
In the present study, new poly(A) trap vectors were devel-
oped in which gene trapping selects for inserted Neo
sequences that splice to the 30 ends of cellular genes. The vec-
tors have additional features that permit vector–cell fusion
transcripts to be directly cloned in Escherichia coli and that
allow genes and chromosomes tagged by gene trapping to
be engineered by DNA site-speciﬁc recombinases (26–31).
The vectors are suitable for large-scale mutagenesis of
mouse ES cells, and we show that most mutations selected
from a stem cell library can be converted to a homozygous
state following selection for higher levels of drug resistance.
The ease and efﬁciency of obtaining homozygous entrapment
mutations will (i) facilitate genetic studies of gene function in
cultured cells, (ii) permit genome-wide studies of recombi-
nation events that result in LOH and mediate a type of
chromosomal instability important in carcinogenesis, and
(iii) provide new strategies for phenotype-driven mutagenesis
screens in mammalian cells.
RESULTS AND DISCUSSION
GTRx.x gene trap vectors (Figure 1a, Supplementary Data)
function as 30 gene [or poly(A)] traps (23–25,32). The virus
inserts a Neo gene throughout the genome, and selection
for G418 resistance generates clones in which Neo sequences
splice to 30 distal exons of cellular genes. The Neo gene in
GTR1.x vectors was expressed from the promoter of the
gene encoding RNA polymerase II (Pol2) (33), or in GTR2.x
vectors from the PGK promoter (34). Expression of the
Figure 1. (a) Structures of the GTR retrovirus gene trap vectors. Expression of an intron-containing Neo gene (50 Neo + 30 Neo) carried by the GTR1.0 poly(A)
trap vector selects for inserts in which the Neo gene, expressed from the promoter of the RNA polymerase 2 gene (Pol2), splices to downstream exons of cellular
genes. Transcripts of occupied cellular genes splice to a 30 exon [consisting of the 30 end of a puromycin-resistance gene (30 Puro), an internal ribosome entry site
(IRES), a lacZ reporter and a polyadenylation site (PA)], disrupting their expression. A wild-type loxP site (loxP, left of 30 Puro) and mutant loxP sites (lox 5171,
on either side of the 30 Neo exon) allow the body of the provirus to be replaced by other sequences by Cre-mediated cassette exchange. An RNA instability
sequence (MI, flash symbol) increases the specificity of gene entrapment by reducing the levels of unspliced Neo transcripts. The positions of the provirus long
terminal repeats (30 and 50 LTRs) are also indicated. Viruses lacking either the message instability sequence (pGTR1.3) or the lox 5171 in the Neo intron
(GTR1.2) or both elements (GTR1.1) have also been constructed. GTR1.4–1.7 are identical to GTR1.0–1.3 except they contain an enhanced green fluorescence
(EGFP) reporter instead of lacZ. GTR2.0–2.3 are identical to GTR1.0–1.3 except Neo is expressed from the PGK promoter. Some elements are not drawn to scale
to enhance clarity. (b) Direct cloning of 30 RACE products. Gene entrapment by GTR vectors generates clones in which the Neo gene (white boxes) is expressed
from transcripts that splice to downstream exons of cellular genes (black boxes). The intron and NotI endonuclease cleavage site in the Neo coding sequence
ensure that only recombinant plasmids that contain cDNA inserts amplified from spliced Neo-cell fusion transcripts can give rise to kanamycin-resistant E.coli.
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sequences from the 30 end of a puromycin-resistance gene, an
internal ribosome entry site (IRES) and a reporter protein
[either a nuclear b-galactosidase (lacZ; GTR1.0–GTR1.3)
or enhanced green ﬂuorescent protein (EGFP; GTR1.4–
GTR1.7)]. Wild-type and mutant [lox5171, (35)] loxP sites
allow provirus inserts to be engineered by recombinase-
mediated cassette exchange (RMCE) (27–29). GTR1.0 and
GTR1.3 contain an additional loxP5171 site located in a
synthetic intron inserted into the Neo gene (Supplementary
Figure 1c). The 30 Puro segment provides the 30 end of a
split puromycin-resistance gene and, when used in combina-
tion with the 50 end of the gene, is designed to select for
Cre-mediated inter- and intra-chromosomal recombination
events, as has been described using a split Hprt gene
(30,31). The split Neo gene in GTR1.0 and GTR1.3 can
also be used for this purpose if the 30 Neo exon is ﬁrst deleted
via recombination at the lox5171 sites.
The Neo gene was engineered by inserting an intron and
a NotI cleavage site by site-directed mutagenesis; neither
modiﬁcation affected the protein coding sequence (Supple-
mentary Data and Supplementary Figure 1c). These features
allow 30 RACE products from spliced fusion transcripts to
be cloned directly in E.coli (Figure 1b). Brieﬂy, fusion
transcripts ampliﬁed by 30 RACE are cleaved with NotI and
ligated to a plasmid (pSCV) containing Neo sequences
upstream of the NotI site under the control of a strong
bacterial promoter. Bacterial clones containing the desired
RACE products are then selected on kanamycin plates. All
steps in the process (expansion and cryopreservation of
neomycin-resistant ES clones, RNA extraction, 30 RACE,
and DNA sequencing) were performed in a 96-well format.
Fusion transcripts were cloned from 70–80% of ES cells
grown in a single well without using nested PCR or highly
competent E.coli, equivalent to the efﬁciency of cloning
30 RACE products manually (28).
30 RACE products from 979 ES cell clones were cloned,
sequenced and compared against the mouse genome,
EST and RefSeq databases using MultiBlaster, a relational
database for performing BLAST searches on large numbers
of DNA sequences (36). A total of 141 sequences contained
repetitive DNA or were derived from probable sister clones
(colonies from the same dish with identical 30 RACE prod-
ucts). Of the remaining 838 sequences, 822 returned sig-
niﬁcant matches with sequences in the mouse genome
sequence (MM). Most were derived from transcribed regions
of the genome, as 568 matched sequences represented in
the Expressed Sequence Tag (EST) database; 505, 371 and
337 matched entries for genes in the UniGene, RefSeq and
Mouse Genome Informatics (MGI) databases, respectively
(Figure 2). The UniGene, RefSeq and MGI matches corre-
spond to genes with increasing degrees of characterization/
annotation. Nearly all matches had P-values <10
 50, and
none was >10
 20. Only 31% of the 30 RACE products
matched mouse genomic sequences (MGSCv3) for which
there was no information to suggest that the provirus had
inserted into a previously identiﬁed gene or transcription
unit. Some of these inserts may reﬂect the presence of either
new genes or additional exons that would extend the bound-
aries of adjacent transcription units. However, many probably
correspond to cryptic or orphan 30 exons, as suggested by
31 RACE products in which the sequence is derived from a
well-characterized gene but in the opposite transcriptional
orientation from the occupied gene. The task of distinguish-
ing between genes and cryptic/orphan 30 exons is complicated
Figure 2. Tagged sequence mutagenesis with the GTR gene trap vectors.
Composition of 30 RACE sequences (a) 838 vector–fusion transcripts cloned
by 30 RACE matched sequences in the mouse genome (MM), expressed
sequence tag (EST) and RefSeq databases, as shown. Matches corresponding
to cellular genes as determined by UniGene and Mouse Genome Informatics
entries (MGI) are also indicated. The positions of GTR inserts in cellular
genes as deduced from the sequence of 30 RACE products. (b) The majority
(217) of inserts in well-characterized genes (304) spliced to the last exon of
cellular genes; of these, 168 contained multiple exons and 49 contained two
exons. (c) Disruption of novel gene sequences by GTR gene trap vectors. The
number of inserts into unique genes (based on UniGene designations) is
plotted against the total number of ES cell clones analyzed. All matches
plotted on the y-axis involved non-repetitive sequences with P-values <
10
 20. ES cell clones plotted on the x-axis included sister clones from the
same dish and clones from which 30 RACE products contained repetitive
(non-informative) DNA sequences.
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scripts in genes, spliced ESTs that are not incorporated into
the structural models of nearby genes and abundant cyto-
plasmic poly(A)-containing RNAs that do not match anno-
tated gene sequences. For comparison, 56% of cytoplasmic
polyadenylated RNAs do not contain annotated exon or
intron sequences (37).
The GTR vectors preferentially targeted the last intron and
expressed fusion transcripts that spliced to a single down-
stream exon (Figure 2b). This provides further evidence
that poly(A) traps select for fusion transcripts that evade
nonsense-mediated decay (28,38). However, the preference
was less pronounced, as 29% of the inserts in well-
characterized genes were in upstream introns.
As with other gene trap vectors, gene targeting was not
random (2,39): 15% of the unique UniGene sequences were
targeted multiple times in clones derived from independent
culture dishes, representing potential preferred sites for
virus integration and/or gene trap selection. These include
7 inserts in 160010M07Rik by different GTR vectors and
11 inserts in CDC57 (4933434G05Rik), all by GTR2.3. The
overall accumulation of gene trap inserts into unique Uni-
Gene clusters (Figure 2c) as a function of the total ES cell
clones analyzed (including sister clones and non-informative
30 RACE products with repetitive sequences) is similar to
that reported for other gene trap vectors (39); however, the
number of mutations analyzed is too small to predict eventual
genome coverage (2,40).
Clones from the entrapment library were highly germline
competent as all 10 entrapment loci that have been tested
to date were readily transmitted through the germline (data
not shown). While detailed analysis of the mutant mice is
outside the scope of the present study, the GTR vectors
appeared to be effective mutagens: 3 of 9 inserts into anno-
tated genes induced obvious phenotypes when bred to a
homozygous state. Speciﬁcally, an insert into Hesx1 produced
similar defects in eye development to those described for a
targeted null mutation (41); the Dymeclin mutation caused
defects in bone growth similar to defects observed in humans
(42); and animals homozygous for the Pfdn1 mutation die
within 5 weeks of age. In all cases examined (Cradd, Dyme-
clin and Pfdn1), entrapment mutagenesis signiﬁcantly ablated
expression of the occupied allele (Figure 3) even though all
occurred in the last intron of the gene. Thus, the entrapment
library provides a resource from which mutations in
genes of interest can be selected for transmission into the
germline. The mutations have been contributed to the Interna-
tional Gene Trap Consortium [IGTC, (2)], and the 30 RACE
sequences have been submitted to the GenBank GSS
(Genome Survey Sequence, http://www.ncbi.nlm.nih.gov/
dbGSS/index.html) database (Accession numbers:
CZ169539–CZ170518). Speciﬁc mutations can be identiﬁed
by searching the GSS database with cDNA sequences of
the genes of interest. Matching database entries provide
information about the mutation, gene trap vector and contact
information for obtaining the ES cell clone. As with any gene
trap mutation, the occupied allele should ﬁrst be evaluated
with regard to the position and orientation of the vector
within the occupied gene, e.g. to avoid inserts where the vec-
tor is in the wrong transcriptional orientation or is located
downstream (30) of protein coding sequences.
We tested whether homozygous mutants could be selected
from heterozygous gene trap clones and examined the inﬂu-
ence of chromosome location on the frequencies of LOH.
A total of 37 randomly selected clones with mutations
(Supplementary Figure 2 and Supplementary Table 1)
induced by the GTR1.3 vector were placed in media contain-
ing 2.0 mg/ml G418 to select potential clones that had under-
gone spontaneous LOH. The frequencies of resistance to
2.0 mg/ml G418 ranged from 1.3 · 10
 5 to 1.2 · 10
 4.
Thus, all 37 clones with inserted GTR1.3 proviruses
expressed degrees of neomycin sensitivity that are required
in order to select for homozygous mutations generated by
gene targeting (16,19). However, clones containing the
GTR2.3 vector (in which Neo is expressed from the PGK pro-
moter) displayed far greater resistance to G418 (Supplemen-
tary Table 1), even at 3.0 mg/ml G418 (data not shown). All
of the GTR vectors were constructed using a ‘mutant’ Neo
gene known to induce lower levels of antibiotic resistance
than a ‘corrected’ variant (20). Nevertheless, the intrinsic
neomycin sensitivity of cells with GTR2.3 proviruses was
insufﬁcient to select for potential LOH events that occur at
per-cell frequencies of  10
 5 (12–16,19). Levels of neomy-
cin resistance correlate with levels of Neo gene expression
(17), and relatively low levels of resistance are necessary in
order to select for LOH events (22). Therefore, use of the
Pol2 promoter, which is four times weaker than the PGK
promoter (28), appears to be an important variable with
regard to the reliable selection of potential homozygous
mutant entrapment clones.
Figure 3. Loss of occupied gene expression in homozygous mutant cells and
tissues. Pfdn1 expression (a, upper panel) in embryonic fibroblast cells from
wild-type (lane 1), homozygous mutant (lane 2) and heterozygous (lane 3)
fibroblasts was analyzed by northern blot analysis. The blot was stripped and
probed with a GAPDH sequence as a loading control (lower panel). Cradd
protein expression (b, upper panel) in primary spleen cells from homozygous
mutant mice (lane 1) and wild type (lane 2) was assessed by western blot
analysis. As a loading control, the blots were stripped and analyzed using an
anti-b-actin antibody (lower panel). Dymeclin expression (c, upper panel) in
liver tissue from wild type (lane 1) and homozygous mutant mice (lane 2) was
analyzed by northern blot analysis. Hybridization to a GAPDH probe (lower
panel) provides a loading control.
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GTR1.3 conﬁrmed that a signiﬁcant proportion (82% overall)
of the colonies surviving in 2.0 mg/ml G418 had undergone
LOH (Figure 4). Cells homozygous for all 12 entrapment
loci tested were recovered at frequencies ranging from
40% to 100% of the high G418-resistant colonies selected
from each clone. The 12 entrapment clones were randomly
selected based on the availability of ﬂanking sequence probes
and primers capable of distinguishing the wild-type and occu-
pied alleles. Since entrapment clones generated by GTR1.3
produced colonies resistant to 2.0 mg/ml G418 at similar
frequencies (Supplementary Table 1), and a high proportion
of the high G418-resistant colonies analyzed from each tested
clone had undergone LOH, we conclude that cells homozy-
gous for most mutations in the gene trap library can be
selected in 2.0 mg/ml G418.
In contrast, we have encountered only one GTR1.3 entrap-
ment clone for which homozygous mutant ES cells could not
be isolated. These experiments (Cao et al., unpublished) were
performed as part of a separate study to characterize a muta-
tion in Pfdn1 (prefoldin), a chaperone that assists in the
folding of cytoskeletal proteins (43). Brieﬂy, cells heterozy-
gous for the Pfdn1 mutation formed colonies in 2.0 mg/ml
G418 at frequencies (5.6 · 10
 6) more than 10-fold lower
than observed with other GTR1.3 entrapment clones and
similar to the frequencies observed with ES cells heterozy-
gous for a targeted mutation in Ssrp1 (data not shown),
which encodes a chromatin remodeling protein essential
for ES cell viability (44). Moreover, the colonies arising in
high G418 were small, and the cells could not be propagated
further. Therefore, prefoldin appears to be required for
the clonal outgrowth of ES cells, accounting for the failure
to isolate homozygous mutant cells.
The frequency of colony formation in high G418 increased
with increasing distance from the centromere (Figure 5). The
R
2 by linear regression analysis was 0.54 for all genes in
aggregate (Figure 5a) and 0.78 for the eight loci on chromo-
some 4 considered separately (Figure 5b). The inﬂuence of
chromosome position was observed despite many potential
variables that could inﬂuence the induction or recovery of
clones with LOH [e.g. levels of Neo expression, DNA
sequence effects on recombination, or clonal variation in
Figure 4. LOH at entrapment loci following selection in 2.0 mg/ml G418. DNAs from the parental ES cells (lane 1), heterozygous mutant entrapment clones
(lane 2) and clones isolated following selection in 2.0 mg/ml G418 (lanes 3–7) were genotyped by either Southern blot hybridization (j, l) or PCR (a–i, k) using
gene-specific probes and primers. The mutant clones contained entrapment vectors inserted in or near (*) the following genes: Ttc18 (a) Rbm4 (b), IL8Ra* (c),
M11t10 (d), Cradd (e), 1700012G11Rik (f), Rnf7 (g), LOC240669 (h), Hesx1 (i), 1810030N24Rik (j), Dscr1l1 (k) and Xrcc5 (l). Bands corresponding to the
wild-type allele migrate more slowly in all cases except (b) than the allele disrupted by gene entrapment. LOH is indicated by the absence of the wild-type allele
in cells selected in high G418 media.
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shown)]. The chromosome position effect suggests that
mitotic recombination plays a signiﬁcant role in spontaneous
LOH, consistent with previous observations involving Neo
genes inserted by gene targeting in ES cells (19) and the
APRT gene in other cell types (13,14,18).
GTR1.3 represents the ﬁrst insertional mutagen capable of
biallelic mutagenesis of mammalian genes. However, like
other early-generation poly(A) traps, the vector preferentially
targets 30 introns, reﬂecting selection for fusion transcripts
that escape nonsense-mediated decay (28,38). This interferes
with the mutagenesis of a subset of genes that lack signiﬁcant
protein coding sequence in the last exon and may limit gen-
ome coverage (40). Inclusion of an IRES in the poly(A) trap
cassette greatly enhances the recovery of inserts positioned
throughout genes and increases the expression of fusion
transcripts that append multiple, downstream exons (38).
The IRES also appears to decrease the proportion of trapping
events that splice to cryptic 30 exons, probably by increasing
the size of the region within genes compatible with gene
trap selection. Alternatively, small, non-coding poly(A) trap
cassettes may be incorporated into a 50 gene trap vector (40).
The ease and efﬁciency of obtaining homozygous entrap-
ment mutations will enhance the utility of mutant ES cell
libraries in several ways. First, cells deﬁcient in any gene
of interest (assuming the gene is expressed in ES cells and
is not required for cell viability) can be readily obtained for
biochemical and metabolic studies of gene function, without
the time or expense of introducing the mutation into the
germline. For example, LOH involving a mutation in the
Xrcc5 gene (Figure 4l) resulted in a complete loss of Xrcc5
expression in the homozygous mutant cells (Figure 6a).
As expected the Xrcc5-deﬁcient cells were also hypersensi-
tive to g-irradiation as compared with the parental or
heterozygous mutant ES cells or cells defective in either
Xrcc6 or Ku86 that display radiation-sensitive phenotypes
(Figure 6b). Second, analysis of homozygous mutants
will be useful in assessing whether gene entrapment has
induced a null mutation as illustrated by the Xrcc5 mutation
Figure 6. Loss of Xrcc5 expression in homozygous entrapment clones. (a)
RNA was isolated from the parental AC1 ES cells (lane 1), the heterozygous
Xrcc5 entrapment mutant before selection in 2.0 mg/ml G418 (lane 2) and
clones isolated by selection in 2.0 G418 (lanes 3–6) and northern blot analysis
was performed using Xrcc5 (downstream of exon 1 cloned by 30RACE) and
b-actin specific probes (upper and lower panels, respectively). Neo–Xrcc5
fusion transcripts in heterozygous and homozygous mutant cells are generated
by splicing of the Neo sequences to exon 2 of the Xrcc5 gene. (b) Radiation
sensitivity of Xrcc5 heterozygous and homozygous mutant cells. Parental ES
cells (1), heterozygous Xrcc5 entrapment mutant (2) homozygous Xrcc5
entrapment mutants homozygous Xrcc5 entrapment mutants (3, 5, 6) a control
Xrcc6-deficient Chinese hamster ovary (CHO) cell line (4) and a radiation-
sensitive CHO cell line (Xrs5) defective in Ku86 were exposed to increasing
doses of g-irradiation, and cell survival was measured in a clonogenic assay.
Figure 5. The frequency of presumptive LOH at sites throughout the genome
increases with distance from the centromere. A total of 37 ES cell clones,
each containing a single GTR1.3 gene trap vector, were placed in media
containing 2.0 and 0.3 mg/ml G418. The frequency of colony formation
(Presumptive LOH) in the higher concentration of G418 (normalized to the
number of colonies at the lower concentration) is plotted against the distance
of each mutation from the centromere. The average values for three
independent experiments are plotted for all 37 entrapment loci (a) and for all
8 inserts located on chromosome 4 (b). Linear regression analyses of the two
groups produced R-squared values of 0.54 and 0.78, respectively. The SD
values, which were 1060% of the average values, have been omitted for
clarity.
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cells will provide an early assessment of whether the
disrupted genes or chromosome deletions engineered post-
entrapment are required for cell viability. Fourth, allelic
imbalance is a common manifestation of chromosome insta-
bility in human cancers, which may harbor >10 000 regions
of LOH per cell (45). The source of this genome-wide
LOH is unknown and unfortunately, frequencies of LOH at
speciﬁc sites are typically measured at relatively few loci
(e.g. Tk, Aprt, Hprt or cell surface antigens) where gene inac-
tivation confers a selectable phenotype. Entrapment ES cell
clones provide resources to study factors, such as carcinogens
(46), localized elements in the genome or mutations in genes
required for genome maintenance, that inﬂuence the frequen-
cies of LOH at many sites throughout the genome.
Finally, LOH involving GTR poly(A) traps will assist
phenotype-driven mutagenesis screens in mammalian cells
(6,7,47). Mutagens incorporating Pol2Neo as an LOH selec-
tion cassette, should facilitate the recovery of homozygous
mutants by combining selection for high G418 resistance
together with strategies that enhance the frequencies of
LOH (7,46,47). Alternatively, since LOH involving inserted
Neo resistance genes extend across large chromosome regions
(19), stem cell clones containing inserted GTR1.3 vectors can
be used to enhance the recovery of homozygous recessive
mutants located on the same chromosome as the gene trap
vector. This provides an alternative to the use of site-speciﬁc
recombinases to induce mitotic recombination (10,11), elimi-
nating the need to insert recombinase target sequences at
allelic sites in the genome.
METHODS
Gene trapping
AC1 mouse ES cells were derived from an explanted 129svJ
blastocyst cultured on feeder layers of irradiated mouse
embryo ﬁbroblasts and were cultured as described previously
(48).
Construction of GTR poly(A) trap vectors is described in
the Supplementary Data. Retroviruses were prepared by
transfecting GTR plasmids into Phoenix Eco cells by calcium
phosphate coprecipitation. Virus production by individual
clones was titered as Neo
R c.f.u. in NIH3T3 cells (28). Super-
natants from producer lines with titers of 200 Neo
R c.f.u./ml
were used to infect AC1 ES cells: 24 h post-infection, the
cells were placed in selective media containing 250 mg/ml
of G418 (Invitrogen) and cultured for 7 days during which
the media was changed every day. Individual G418-resistant
colonies were transferred to a single well of a 96-well plate.
After 3–5 days, the plates were passaged to three 96-well
plates and grown for an additional 2–3 days. One plate was
used to prepare RNA for 30 RACE and two plates were cry-
opreserved in liquid nitrogen.
Identification of genes disrupted by gene entrapment
Disrupted genes were identiﬁed by sequencing cloned Neo
fusion transcripts ampliﬁed by 30 RACE. Total RNA was
extracted using the RNeasy96 system (Qiagen Inc, Valencia,
CA) according to the manufacturer’s instructions. cDNA was
synthesized using the superscript II reverse transcrtiptase
(Invitrogen) in a 20-ml reaction containing 1 mg of total
RNA and a NotI-adaptor-oligo-dT primer (50-GACTAAC-
CCGGCTCGAGCGGCCGCTTTTTTTTTTTTTTTTTT-30).
The cDNA was then ampliﬁed by two rounds of PCR in a
50-ml reaction using the hotstart Taq polymerase kit (Qiagen).
The PCR contained 2 ml of the above cDNA product with a
Neo-speciﬁc primer (50-ATGGCCGCTTTTCTGGATTCAT-
CG-30) and NotI adaptor primer (50-GACTAACCCGGCT-
CGAGCGGCCGCT-30). All the reactions were performed
in 96-well plates. PCR products were puriﬁed using
QIAquick 96 cartridges (Qiagen) and digested with NotI for
1 h and then puriﬁed again over QIAquick 96.
NotI-digested 30 RACE products were ligated together with
the selective cloning vector (pSCV, see Supplementary Data)
and transferred into chemically competent DH5a E.coli. The
transformed cells were cultured for 2 h in Luria–Bertani (LB)
media and plated on LB agar plates containing 25 mg/ml
kanamycin. Individual colonies were picked and grown in
96-well ml LB media overnight. Plasmids were prepared
with QIAprep 96 Miniprep cartridges (Qiagen) and
sequenced (28), using a Neo-speciﬁc primer: TCCCGATTC-
GCAGCGCATCGCC. It should be noted that pSCV incorpo-
rates the ‘corrected’ Neo sequence (20). Selective cloning
vectors incorporating the less active variant formed far
fewer colonies on 25 mg/ml kanamycin plates (Q.L., unpub-
lished). When entrapment clones were grown on Neo-
resistant feeder layer cells, 30 RACE also generated small
inserts, of 110 nt in size, generated by recombination between
the fusion transcripts (which contain a NotI site) and Neo
transcripts expressed by the feeder cells. To eliminate this
background, plasmids were pre-screened to identify clones
with larger RACE products.
Isolation of flanking genomic DNA
Flanking genomic DNA sequences were cloned by inverse
PCR (49) or by ligation-mediated PCR (50) modiﬁed by
the addition of a C3 spacer (Integrated DNA Technologies)
to the NlaIII minus adaptor to block the ampliﬁcation of frag-
ments via adaptor primers alone. Brieﬂy, genomic DNA was
(i) digested with NlaIII, ligated to a 1:1 mixture of NlaIII plus
(50-GTAATACGACTCACTATAGGGCTCCGCTTAAGGG-
ACCATG-30) and minus (50-Phos-GTCCCTTAAGCGGAG-
C3 spacer) strand adaptors, (ii) digested with PstI to prevent
ampliﬁcation of sequences from the 50 LTR and (iii) subjected
to two rounds (30 cycles each) of PCR using nested primers to
the LTR and adaptor sequences.
First round PCR, LTR: 50-GCTAGCTTGCCAAACCTA-
CAGGTGG-30
Adaptor: 50-GTAATACGACTCACTATAGGGCTCCG-30
Second round PCR, LTR: 50-CCAAACCTACAGGTG-
GGGTCTTTC-30
Adaptor: 50-AGGGCTCCGCTTAAGGGAC-30
Regions of ﬂanking genomic DNA downstream of the pro-
virus in the Ttc18, Rbm4, M11t10, Cradd, 1700012G11Rik,
Rnf7, LOC240669, Hesx1 and Dscr1l1 genes or near the
IL8Ra gene were sequenced, and the sequences have been
submitted to the GenBank GSS database (accession numbers,
DX977440–DX977449, respectively). The sequences of
primers used for genotyping are available on request.
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Serially diluted cells were plated in triplicate onto 150 mm
plates and allowed to attach overnight. Subsequently, unat-
tached cells were removed and selection media containing
either 0.0, 0.3 or 2.0 mg/ml G418 was added to each dish.
After 12 days, the number of colonies surviving in each
dish was counted, and the frequency of colony formation at
2.0 mg/ml G418 was determined by dividing the number of
colonies obtained from 0.3 mg/ml G418 selection to that
obtained from 2.0 mg/ml G418 selection.
The genotypes of clones surviving in 2.0 mg/ml G418 were
determined by Southern blot and PCR analysis. For Southern
blot analysis, 5 mg of endonuclease-cleaved DNA was frac-
tionated on 0.9% (w/v) agarose gels and hybridized to probe
genomic DNA sequences adjacent to the entrapment vector.
For PCR analysis, 200 ng of genomic DNA was ampliﬁed
using two primers complementary to genomic DNA located
on either side of the site of provirus insertion and one primer
speciﬁc for the entrapment vector.
Loss of Cradd expression in homozygous mutant cells was
determined by western blot analysis using a rabbit polyclonal
antibody against a region containing Leu-97 of the human
CRADD/RAIDD protein (catalog number 4899, Cell Signal-
ing Technology, Inc.)
Analysis of Xrcc5 entrapment clones
Serially diluted cells were plated in triplicate onto 150 mm
plates and allowed to attach overnight. Subsequently, cells
were irradiated in culture medium at a dose rate of 3 Gy/min
(200 kV, 4 mA, 0.78 mm A1). Colonies were counted at
12 days after irradiation, and the percentage of surviving
cells was determined relative to the numbers of colonies
from untreated cells.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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